TuHURA draws additional $1.5M under amended loan; total $3M, issues warrants

TuHURA Biosciences, Inc./NV

Borrowed an additional $1.5M on Dec 2, 2025, bringing aggregate loans to $3.0M under the Loan Agreement.
Amendment extends availability period to Dec 5, 2025 and sets warrants at 150K shares per $1.5M borrowed.
Issued warrant to purchase 234,783 shares at $1.81/share, expiring in two years.
Lender is Matthew Nachtrab Revocable Trust; warrants cover both the initial and second loan advances.

item 1.01 item 2.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

TuHURA Biosciences, Inc./NV incurred loan of $1.5 million with Matthew Nachtrab Revocable Trust dated 12/18/2014.

Instrument: loan
Principal: $1.5 million
Counterparty: Matthew Nachtrab Revocable Trust dated 12/18/2014
Event: incurrence

Exact text from the filing

the Company borrowed an additional $1.5 million from the Lender under the Loan Agreement (the “Second Loan”), which resulted in aggregate Loans of $3.0 million made to the Company under the Loan Agreement.

View on SEC.gov

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

TuHURA Biosciences, Inc./NV amended loan with Matthew Nachtrab Revocable Trust dated 12/18/2014.

Instrument: loan
Counterparty: Matthew Nachtrab Revocable Trust dated 12/18/2014
Event: amendment

Exact text from the filing

(the “Company”) on October 31, 2025, the Company previously entered into a Secured Promissory Note and Loan Agreement, dated October 27, 2025 (the “Loan Agreement”), with the Matthew Nachtrab Revocable Trust dated 12/18/2014 (the “Lender”). Pursuant to the terms of the Loan Agreement, the Lender agreed to make loans to the Company in an aggregate principal amount of up to $3.0 million (the “Loans”) during a 30-day availability period beginning on the date of the Loan Agreement (the “Availability Period”).

View on SEC.gov

306 debt financings filed in the last 30 days. Browse all debt financings →

TuHURA Biosciences, Inc./NV filing history →

Source: SEC EDGAR

accession 0001193125-25-309853

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.